Campus alert status is yellow: For the latest campus alert status, news and resources, visit umassmed.edu/coronavirus

Search Close Search
Search Close Search
Page Menu

Vision Seminar Series

Total: displaying 15 out of 39 results
  • Low-Dose Recombinant Adeno-Associated Virus-Mediated Inhibition of Vascular Endothelial Growth Factor Can Treat Neovascular Pathologies Without Inducing Retinal Vasculitis
    Wednesday, November 10, 2021

    Low-Dose Recombinant Adeno-Associated Virus-Mediated Inhibition of Vascular Endothelial Growth Factor Can Treat Neovascular Pathologies Without Inducing Retinal Vasculitis

    The Department of Ophthalmology & Visual Sciences at the University of Massachusetts Medical School is happy to announce our next speaker Shun-Yun Cheng, PhD

    Read more
  • Endovascular Treatment of Medically Refractory Idiopathic Intracranial Hypertension
    Wednesday, October 13, 2021

    Endovascular Treatment of Medically Refractory Idiopathic Intracranial Hypertension

    Jasmeet Singh, MD, Associate Professor of Neurointerventional Radiology; Program Director, Neurointerventional Radiology Fellowship Program, UMass Memorial Medical Center.

    Read more
  • Invisibility of Scotomas: Understanding Visual Field Loss
    Wednesday, September 08, 2021

    Invisibility of Scotomas: Understanding Visual Field Loss

    Eli Peli, MSc, OD Professor of Ophthalmology, Harvard Medical School, Senior Scientist, Moakley Scholar in Aging Eye Research, Schepens Eye Research Institute Massachusetts Eye and Ear

    Read more
  • Retinal Degeneration: A Slippery Tale of Two Isoprenoids
    Wednesday, May 19, 2021

    Retinal Degeneration: A Slippery Tale of Two Isoprenoids

    Steven J. Fliesler, PhD, FARVO, SUNY Distinguished Professor, Meyer H. Riwchun Endowed Chair, Professor of Ophthalmology, Vice-Chair for Research, Department of Ophthalmology, Director, Ira G. Ross Eye Institute Vision Research Center, University at Buffalo, The State University of New York (SUNY)

    Read more
  • Genetics and AREDS Formula Interaction in Wet AMD
    Monday, April 26, 2021

    Genetics and AREDS Formula Interaction in Wet AMD

    Pradeepa Yoganathan, MD, MSc, FRCSC, Associate Professor, Department of Ophthalmology Vision and Anatomical Sciences, Wayne State University, Assistant Professor, Department of Ophthalmology and Vision Sciences, University of Toronto

    Read more
  • Pathophysiology and Treatment of Retinopathy of Prematurity
    Monday, March 29, 2021

    Pathophysiology and Treatment of Retinopathy of Prematurity

    Mary Elizabeth Harnett, MD, Distinguished Professor in Ophthalmology and Visual Sciences, University of Utah Calvin S. and JeNeal N. Hatch Presidential Endowed Chair in Ophthalmology and Visual Sciences Director of Pediatric Retina. Principal Investigator Retinal Angiogenesis Laboratory, John A. Moran Eye Center.

    Read more
  • Generating New Neurons and Protecting Old Neurons in Vision Restoration
    Thursday, February 25, 2021

    Generating New Neurons and Protecting Old Neurons in Vision Restoration

    Bo Chen, PhD, Associate Professor, Director of Ocular Stem Cell Program, Department of Ophthalmology, Department of Neuroscience, Department of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai

    Read more
  • Gene Therapy for GUCY2D, Leber Congenital Amaurosis, From Bench to Bedside
    Friday, January 29, 2021

    Gene Therapy for GUCY2D, Leber Congenital Amaurosis, From Bench to Bedside

    Shannon E. Boye, PhD, Associate Professor of Pediatrics/Associate Chief, Division of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida

    Read more
  • Retinal Polarization Scanning: A New Strategy for Amblyopia Detection and Traumatic Brain Injury Assessment
    Wednesday, December 30, 2020

    Retinal Polarization Scanning: A New Strategy for Amblyopia Detection and Traumatic Brain Injury Assessment

    David G. Hunter, MD, PhD, Ophthalmologist-in-Chief and Richard M. Robb Chair at Boston Children’s Hospital, Professor and Vice Chair of Ophthalmology, Harvard Medical School

    Read more
  • The Role of Reflective Practice in Resident Development
    Tuesday, November 03, 2020

    The Role of Reflective Practice in Resident Development

    Laura Wayman, MD, Professor and Vice Chair for Education, James H. Elliot Endowed Director, Department of Ophthalmology, Vanderbilt University Medical Center.

    Read more
  • The Ocular Hypertension Treatment Study- 20 Years Later
    Thursday, October 15, 2020

    The Ocular Hypertension Treatment Study- 20 Years Later

    Joern B. Soltau, MD, Associate Professor and Chair, Department of Ophthalmology and Visual Sciences, Dr. William H. and Mrs. Blondina F. Evans Endowed Chair Kentucky Lions Eye Center

    Read more
  • What is Driving Socioeconomic and Racial/Ethnic Inequities in Health?
    Thursday, September 17, 2020

    What is Driving Socioeconomic and Racial/Ethnic Inequities in Health?

    This seminar provides an overview of key social determinants of health, unpacks the underlying drivers of socioeconomic and racial/ethnic health inequities in the U.S., and promotes discussion of opportunities to advance health equity in health care.

    Read more
  • A Walk Through the Glaucoma Park
    Thursday, December 19, 2019

    A Walk Through the Glaucoma Park

    Christopher Teng MD, Associate Professor of Ophthalmology and Visual Science at Yale University School of Medicine and the Vice Chair for Clinical Affairs and Director of the Glaucoma Service and Glaucoma Fellowship was our Vision Seminar’s first speaker in 2020.

    Read more
  • Saving Sight: Three Unsung Heroes and How They Changed the Way We See
    Friday, November 22, 2019

    Saving Sight: Three Unsung Heroes and How They Changed the Way We See

    Andrew Lam, M.D., is a retinal surgeon and award-winning author of three books: Saving Sight, an Amazon bestseller about his surgical career, Two Sons of China, a novel of WWII that won a Foreword Reviews' Book of Year Award in 2014, and his latest novel, Repentance, based on the history of the famed Japanese American 442nd Regimental Combat Team of WWII.

    Read more
  • Artificial Intelligence and the Future of Ophthalmology
    Wednesday, October 02, 2019

    Artificial Intelligence and the Future of Ophthalmology

    Judy E. Kim, MD is an internationally well-known vitreoretinal specialist and a Professor of Ophthalmology with tenure at the Medical College of Wisconsin. Dr. Kim was the honorable guest speaker of the October Vision Seminar and discussed the interesting topic of Artificial Intelligence (AI) in ophthalmology.

     

    Read more
  • Sickle Cell Retinopathy: Diagnosis, Management and Research
    Thursday, August 22, 2019

    Sickle Cell Retinopathy: Diagnosis, Management and Research

    Jennifer Lim, MD, the Marion H. Schenk Chair Professor of Ophthalmology, and the director of the Retina Service, University of Illinois at Chicago, Illinois Eye and Ear Infirmary in Chicago, was the honorable first Vision Seminar guest for the new academic year. She skillfully summarized the history and the current clinical approach to the diagnosis and management of sickle cell retinopathy.

    Read more
  • UMass Ophthalmology at ARVO 2019
    Wednesday, May 22, 2019

    UMass Ophthalmology at ARVO 2019

    Several members of the Department of Ophthalmology & Visual Sciences, UMASS Medical School participated in the ARVO 2019 annual meeting from April 28-May 3, 2019 in Vancouver, British Columbia. The participants also presented their findings at the Ophthalmology Vision seminar series on June 20, 2019 at the UMASS Medical School. Here are the highlights of their presentation day:

    Read more
  • Fuchs Corneal Dystrophy: Past, Present and Future
    Wednesday, March 27, 2019

    Fuchs Corneal Dystrophy: Past, Present and Future

    Kathryn Colby, MD, PhD, an internationally renowned academic cornea specialist, was April’s Vision Seminar guest speaker. Dr. Colby serves as Chair of Ophthalmology at the University of Chicago, where she is the Louis Block Professor. She discussed a special prevalent corneal condition, common in women, named: Fuchs’ dystrophy, which is the most common cause for corneal transplantation in the US.

    Read more
  • Pyruvate Kinase M2 Regulates Photoreceptor Structure, Function, and Viability
    Saturday, February 16, 2019

    Pyruvate Kinase M2 Regulates Photoreceptor Structure, Function, and Viability

    The Department of Ophthalmology & Visual Sciences at UMASS Medical School kicked off spring with our distinguished vision seminar speaker Dr. Raju V.S. Rajala, PhD, M.G. McCool Chair in Ophthalmology and Professor of Physiology at the University of Oklahoma Health Sciences Center.

    Read more
  • Programmed Bone Marrow-derived Cells as a Systemic Therapy for Retinal Degeneration
    Sunday, December 23, 2018

    Programmed Bone Marrow-derived Cells as a Systemic Therapy for Retinal Degeneration

    Michael E Boulton, the Susan and Dowd Ritter/RPB Endowed Chair and Professor in Ophthalmology Research, University of Alabama, former Head of the School of Optometry and Vision Sciences, Cardiff University, UK, was the honorable guest speaker of January’s Vision Seminar.

    Read more
  • Posterior Vitreous Detachment: Evolution, Complications, and Treatment of Its Early Stages
    Sunday, October 28, 2018

    Posterior Vitreous Detachment: Evolution, Complications, and Treatment of Its Early Stages

    Mark Johnson, MD, Professor of Ophthalmology and Visual Sciences at the Kellogg Eye Center at the University of Michigan was the honorable guest speaker of November’s Vision Seminar.

    Read more
  • Future Treatments for Age-related Macular Degeneration
    Wednesday, September 05, 2018

    Future Treatments for Age-related Macular Degeneration

    Joan Miller, MD, FARVO, the David Glendenning Cogan Professor of Ophthalmology and Chair of Ophthalmology at Harvard Medical School was the Vision Seminar distinguished speaker in September 2018. Dr. Miller also serves as Chief of Ophthalmology at Massachusetts Eye and Ear and Massachusetts General Hospital.

     

    Read more
  • UMass Ophthalmology at ARVO 2018
    Wednesday, May 23, 2018

    UMass Ophthalmology at ARVO 2018

    Members of the Department of Ophthalmology & Visual Sciences, UMASS Medical School participated in the ARVO 2018 annual meeting from April 29-MAy 3, 2018 in Hawaii. The participants also presented their findings at the Ophthalmology Vision seminar series on June 21, 2018 at the UMASS Medical School. Here are the highlights of their presentation day:

     

    Read more
  • Regenerative Medicine in the Management of Vitreoretinal Disorders
    Wednesday, April 25, 2018

    Regenerative Medicine in the Management of Vitreoretinal Disorders

    Vision Seminar guest speaker, Lucian Del Priore, MD, PhD, chair of the Department of Ophthalmology and Visual Science at Yale University and chief of ophthalmology at Yale New Haven Hospital (YNHH), summarized decades of basic bench research and advanced clinical research in the field of stem cell transplantation.

    Read more
  • Cone Photoreceptor Regeneration and Return of Vision
    Saturday, April 07, 2018

    Cone Photoreceptor Regeneration and Return of Vision

    Henry J. Kaplan MD, FACS, was April’s Vision Seminar guest speaker. He summarized the work he has been doing over the past decade with collaborators at the University of Louisville, and other universities across the nation. His research team has found a way to revitalize cone receptors that have deteriorated as a result of the blinding disease, retinitis pigmentosa (RP).

    Read more
  • Cytosolic Nuclear DNA Fragments in Age Related Macular Degeneration Pathogenesis
    Thursday, February 22, 2018

    Cytosolic Nuclear DNA Fragments in Age Related Macular Degeneration Pathogenesis

    Haijiang Lin M.D., Ph.D, a clinician-scientist concentrating on the field of retinal diseases is the Director of the Department of Ophthalmology & Visual Sciences Translational Research Center. He gave a special Vision Seminar talk discussing the role of cytosolic accumulation of nuclear DNA (nDNA) in Age-related macular degeneration (AMD) pathogenesis.

    Read more
  • Infectious Keratitis: Lessons from the SCUT and MUTT Trials
    Saturday, January 27, 2018

    Infectious Keratitis: Lessons from the SCUT and MUTT Trials

    Dr. Zegans is a Professor of Surgery and Professor of Microbiology and Immunology at Dartmouth College. He currently serves as the Chair of the Department of Ophthalmology at Dartmouth College.

    Read more
  • Pearls and Pitfalls in the Management of Retinal Degenerations
    Sunday, December 24, 2017

    Pearls and Pitfalls in the Management of Retinal Degenerations

    Dr. Thiran Jayasundera, Associate Professor at the Kellogg Eye Center at the University of Michigan was the Vision Seminar honorable speaker for the month of January. He specializes in the diagnosis and treatment of inherited retinal degenerative diseases, including Stargardt disease, retinitis pigmentosa variants, cone dystrophies and unusual retinal dystrophies.

    Read more
  • Altered Retinal Vascular Basement Membrane and its Role in Diabetic Retinopathy
    Thursday, October 19, 2017

    Altered Retinal Vascular Basement Membrane and its Role in Diabetic Retinopathy

    On Thursday October 19, 2017 the Vision Seminar Series was very pleased to host the guest speaker, Sayon Roy Ph.D., who is a world-renowned scientist in the field of diabetic retinopathy. Diabetic retinopathy remains leading cause for vision impairment in both developed and developing countries affecting over 600 million worldwide.

    Read more
  • Towards New Treatments In Macular Degeneration
    Thursday, September 21, 2017

    Towards New Treatments In Macular Degeneration

    On Thursday September 21, 2017 the Vision Seminar Series was very pleased to host the guest speaker, Demetrious Vavvas M.D., Ph.D., who is a world-renowned retina surgeon and a clinician-scientist. Age-related macular degeneration (AMD) remains the leading cause of blindness in developed countries, and affects more than 150 million worldwide.

    Read more
  • The Persistence of Intensive Glycemic Control and the Use of Fenofibrate in Diabetic Retinopaty: The ACCORD Eye Study of Type 2 Diabetes
    Thursday, June 15, 2017

    The Persistence of Intensive Glycemic Control and the Use of Fenofibrate in Diabetic Retinopaty: The ACCORD Eye Study of Type 2 Diabetes

    June's honorable guest speaker was Dr. Emily Chew, a world-renowned medical retina expert. Dr. Chew is the deputy director of the Division of Epidemiology and Clinical Applications and the deputy clinical director at the National Eye Institute (NEI), National Institutes of Health (NIH).

    Read more
  • UMass Ophthalmology at ARVO 2017 (Association for Research in Vision and Ophthalmology)
    Thursday, May 18, 2017

    UMass Ophthalmology at ARVO 2017 (Association for Research in Vision and Ophthalmology)

    The Vision Seminar Series debut on Thursday, May 18, 2017 was the first mini-symposia with speakers who presented their research at the annual 2017 ARVO (Association for Research in Vision and Ophthalmology) meeting, which was held in Baltimore, USA. The topics ranged from basic to clinical and educational science and were presented by post-doctoral research fellows and medical students.

    Read more
  • Addressing Unmet Needs in Retinal Disease
    Thursday, March 16, 2017

    Addressing Unmet Needs in Retinal Disease

    The Vision Seminar was very pleased to host Jeffrey S. Heier, M.D., the Co-President and Medical Director, Director of the Vitreoretinal Service, and Director of Retina Research at Ophthalmic Consultants of Boston (OCB), as the honorable guest speaker for March.

    Read more
  • Study of the Mechanism of Lipofuscin Accumulation in Model of Best Disease, and the Distinct Transcriptome of RPE Cells Facing Cone Photoreceptors
    Wednesday, February 15, 2017

    Study of the Mechanism of Lipofuscin Accumulation in Model of Best Disease, and the Distinct Transcriptome of RPE Cells Facing Cone Photoreceptors

    On Thursday February 16, 2017 the Vision Seminar Series was very pleased to host its first international guest speaker, Shadi Safuri M.D., Ph.D., who is currently an ophthalmology resident at the at Rambam Medical Center in Haifa, Israel. Dr. Safuri came to UMass to complete an Advanced Ocular Imaging Rotation within the Department of Ophthalmology & Visual Sciences at the Eye Center at UMass Memorial Healthcare.

    Read more
  • Understanding the Pathogenesis of, and Developing Treatment Strategies for X-linked RP & LCA
    Wednesday, January 18, 2017

    Understanding the Pathogenesis of, and Developing Treatment Strategies for X-linked RP & LCA

    On Thursday January 19, 2017 Dr. Hemant Khanna highlighted critical roadblocks in designing gene augmentation therapy for X-linked retinal degeneration due to RPGR mutations. He also provided insights into developing novel therapeutic molecules for treating childhood blindness disorder Leber congenital amaurosis due to CEP290 mutations. Dr. Khanna’s lecture is a part of the UMass Ophthalmology & Visual Sciences Vision Seminar Series.



    Read more
  • Early Changes in Diabetic Retinas Revealed by a Novel Method that Quantifies SD-OCT Images
    Wednesday, November 16, 2016

    Early Changes in Diabetic Retinas Revealed by a Novel Method that Quantifies SD-OCT Images

    November’s vision seminar attracted more than 50 people. The crowd was diverse, and included academic clinical and research faculty from the UMass Medical School, as well as medical students, bioengineering students, research scholars and community ophthalmologists.

    Read more
  • Gene and Drug Based Therapy in Mouse Model of Retinal Degeneration
    Thursday, October 20, 2016

    Gene and Drug Based Therapy in Mouse Model of Retinal Degeneration

    Dr. Manas Biswal from the University of Florida presented research on a new mouse model for age-related macular degeneration (AMD). The model, which increases oxidative stress in the retinal-pigmented epithelium (RPE) by loss of the Sod2 gene, develops some of the hallmarks of Age-related Macular degeneration and will allow for the screening of drugs that reduce oxidative stress in the retinal-pigmented epithelium.


     

    Read more
  • New Findings in Select Cases of Drug/Vaccine Induced Uveitis
    Thursday, September 15, 2016

    New Findings in Select Cases of Drug/Vaccine Induced Uveitis

    On Thursday September 15, 2016 Dr. David Hinkle presented key novel finds associated with Drug/Vaccine induced Uveitis part of the UMass Ophthalmology & Visual Sciences Vision Seminar Series. The presentation was informative and enjoyable, which introduced interesting topics for discussion.

    Read more
  • Insulin/mTOR Signaling
    Thursday, August 18, 2016

    Insulin/mTOR Signaling

    The Department of Ophthalmology & Visual Sciences at the University of Massachusetts Medical School launches a NEW Vision Seminar Series that is open to the public inviting practicing ophthalmologists form the surrounding neighborhoods to share their experiences and knowledge with scientists and clinicians of the Department of Ophthalmology.


    Read more